All Stories

  1. Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

    Article • Patient Related Outcome Measures, December 2019, Taylor & Francis

    Dejan Jakimovski, Osman OZEL

  2. Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study

    Article • Multiple Sclerosis Journal, October 2019, SAGE Publications

    Dejan Jakimovski

  3. Decrease in secondary neck vessels in multiple sclerosis: A 5-year longitudinal magnetic resonance angiography study

    Article • Current Neurovascular Research, June 2019, Bentham Science Publishers

    Dejan Jakimovski

  4. Vascular aspects of multiple sclerosis: emphasis on perfusion and cardiovascular comorbidities

    Article • Expert Review of Neurotherapeutics, May 2019, Taylor & Francis

    Dejan Jakimovski

  5. Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study

    Article • Multiple Sclerosis Journal, February 2019, SAGE Publications

    Dejan Jakimovski

  6. Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients

    Article • Multiple Sclerosis Journal, January 2019, SAGE Publications

    Dejan Jakimovski

  7. Quantitative susceptibility mapping (QSM) with an extended physical model for MRI frequency contrast in the brain: a proof-of-concept of quantitative susceptibility and residual (QUASAR) mapping

    Article • NMR in Biomedicine, September 2018, Wiley

    Dejan Jakimovski

  8. Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study

    Article • Journal of Neuroimaging, September 2018, Wiley

    Dejan Jakimovski

  9. Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study

    Article • European Journal of Neurology, September 2018, Wiley

    Dejan Jakimovski

  10. Hemostasis biomarkers in multiple sclerosis

    Article • European Journal of Neurology, June 2018, Wiley

    Dejan Jakimovski

  11. Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study

    Article • Human Brain Mapping, June 2018, Wiley

    Dejan Jakimovski

  12. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis

    Article • Journal of Neuroimaging, June 2018, Wiley

    Dejan Jakimovski

  13. Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS

    Article • Journal of Neuroimaging, May 2018, Wiley

    Dejan Jakimovski

  14. White matter tract network disruption explains reduced conscientiousness in multiple sclerosis

    Article • Human Brain Mapping, May 2018, Wiley

    Dejan Jakimovski

  15. The role of high-frequency MRI monitoring in the detection of pathological brain atrophy in MS.

    Article • Journal of Neuroimaging, February 2018, Wiley

    Dejan Jakimovski, Dr. Tomas TU Uher

  16. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study

    Article • European Journal of Neurology, February 2018, Wiley

    Dejan Jakimovski

  17. Neck Vessel Cross-Sectional Area Measured with MRI: Scan-Rescan Reproducibility for Longitudinal Evaluations

    Article • Journal of Neuroimaging, December 2017, Wiley

    Dejan Jakimovski

  18. Ocrelizumab: a B-cell depleting therapy for multiple sclerosis

    Article • Expert Opinion on Biological Therapy, July 2017, Taylor & Francis

    Dejan Jakimovski

  19. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study

    Article • Journal of Neuroimaging, May 2017, Wiley

    Dejan Jakimovski, Dr. Tomas TU Uher

  20. An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study

    Article • Journal of Neuroimaging, December 2016, Wiley

    Dejan Jakimovski

  21. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study

    Article • Multiple Sclerosis Journal, November 2016, SAGE Publications

    Dejan Jakimovski

  22. A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dr. Tomas TU Uher, Dejan Jakimovski

  23. Brain atrophy measurements should be used to guide therapy monitoring in MS – YES

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dejan Jakimovski

  24. Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease

    Article • Phlebology The Journal of Venous Disease, July 2016, SAGE Publications

    Dejan Jakimovski

  25. Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years

    Article • European Journal of Neurology, March 2016, Wiley

    Dejan Jakimovski

  26. The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing‐Remitting Multiple Sclerosis

    Article • Journal of Neuroimaging, September 2015, Wiley

    Dejan Jakimovski

  27. Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later

    Article • Multiple Sclerosis Journal, September 2015, SAGE Publications

    Dr. Tomas TU Uher, Dejan Jakimovski

  28. Predictors of disease activity in CIS (multiple sclerosis) patients

    Article • European Journal of Neurology, April 2015, Wiley

    Dr Tomas Kalincik, Dr. Tomas TU Uher, Dejan Jakimovski

  29. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease

    Article • Journal of Neuroimaging, March 2015, Wiley

    Dejan Jakimovski

  30. No Regional Gray Matter Atrophy Differences between Pediatric‐ and Adult‐Onset Relapsing‐Remitting Multiple Sclerosis

    Article • Journal of Neuroimaging, January 2013, Wiley

    Dejan Jakimovski

  31. Heart disease, overweight, and cigarette smoking are associated with increased prevalence of extra-cranial venous abnormalities

    Article • Neurological Research, October 2012, Taylor & Francis

    Dejan Jakimovski

  32. Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study

    Article • Neurological Research, October 2012, Taylor & Francis

    Dejan Jakimovski